Please login to the form below
Biogen and Denali dose first patients with LRRK2 inhibitor in Parkinson’s disease study
Mutations in the LRRK2 gene are one of the most common causes of familial Parkinson’s disease
Incyte to acquire Villaris Therapeutics to expand inflammation and autoimmunity portfolio
Auremolimab, which has proven efficacy for vitiligo, is included in the deal
Dexcom launches next-generation continuous glucose monitor for diabetes patients
The monitor allows patients to track their glucose levels without using a finger prick test
WHO unveils new initiative to halt spread of invasive malaria vector in Africa
Anopheles stephensi thrives in urban settings, where 40% of the population in Africa live
NHS England launches lung cancer awareness drive in country’s cancer hotspots
Only 57% of those surveyed recognised a persistent cough as a symptom of lung cancer
The Gallery
<>A visual showcase of agency work. Track down an agency from the image, track down your competitors' work, search by product or therapy area to pull up, for example, cardiovascular campaigns. Click here for a portfolio of hundreds of campaign visuals – updated regularly – free for you to reference. Agencies – to add your work to The Gallery please contact us.
Agency:
Life Healthcare CommunicationsProduct:
Self PromotionClient:
Self PromotionTherapy area:
Self Promotion
Havas Health & You appoints Laura Mizrahi as chief creative officer of H4B Chelsea
Mizrahi joins the agency from her role as executive creative director at FCB Health NY
OPEN Health appoints Stephen Chick as chief growth officer for Evidence & Access
Chick joins the consultancy from his role as vice president of business development at Symphony Health
Subscribe to our email news alerts
Featured jobs
- Business Development Director, Medical Education - exciting new ...
-
Up to £120K base
- Commercial Director, Medical Education, UK six figure package
-
Six figure salary
- Associate Vice President, Scientific Services, Medical Communica...
-
Highly competitive salary
- Scientific Team Leader, Scientific Services, Medical Communicati...
-
Highly competitive salary
- Biogen to pay $900m to settle whistleblower’s MS drug kickback lawsuit
- Biogen and Eisai’s lecanemab shows promise in confirmatory Alzheimer’s study
- Amylyx’s Relyvrio receives FDA approval for ALS treatment
- Sanofi and Regeneron’s Dupixent approved by FDA for prurigo nodularis
- Cancer Research UK scientists announce ‘breakthrough’ in understanding of metastasis
- Janssen’s Erleada combination accepted in Scotland for prostate cancer
- The Holy Grail of healthcare pricing
- Biogen and Denali dose first patients with LRRK2 inhibitor in Parkinson’s disease study
- Incyte to acquire Villaris Therapeutics to expand inflammation and autoimmunity portfolio
- KOL Insights in a Digital World
- Dexcom launches next-generation continuous glucose monitor for diabetes patients
- Report: Reinventing product and portfolio value for the biopharmaceutical industry
- AstraZeneca’s Tezspire receives MHRA approval as add-on treatment for severe asthma
- A man walks into a surgery: The role of storytelling in pharma marketing
- Pharmacogenomics supports and new era of precision medicine
- Amylyx’s Relyvrio receives FDA approval for ALS treatment
- Biogen and Denali dose first patients with LRRK2 inhibitor in Parkinson’s disease study
- COVID-19 linked to long-term neurologic disorders in new US study
PMHub
COUCH Health
We are a patient engagement agency committed to making clinical study experiences human. By guiding organisations in making everything they...Latest intelligence
- Report: Reinventing product and portfolio value for the biopharmaceutical industry
- Gain practical advice on determining and communicating product and portfolio value, including why, in fast-paced and evolving markets, you need to consider the evidence requirements of a growing network of...
- How AI is finally helping rare diseases gain more than just attention
- By Neil Thompson...
- Is communication failing us?
- Compelling people to care in a world oversaturated with news and information...
